American Society for Tropical Medicine and Hygiene

On June 17, Research!America hosted a Capitol Hill briefing on neglected tropical diseases in partnership with Drugs for Neglected Diseases initiative (DNDi), Global Health Technologies Coalition (GHTC), The American Society for Tropical Medicine and Hygiene, and Doctors Without Borders/Médecins Sans Frontières (MSF). Research!America also led a series of Hill meetings last week with influential congressional offices to discuss some of the successes of USAID’€™s NTD program and to highlight the need for continued investments. USAID’€™s NTD program ’€“ which was authorized by Congress in 2006 – has helped to deliver more than 580 million treatments to approximately 260 million people...
NTDs briefing On Monday, June 17, Research!America hosted a Hill briefing , ’€œThe Role of the U.S. Government and the Case for Scaling Up Treatment and Accelerating Innovation for the World’€™s Most Neglected Patients.’€ The event was sponsored by Reps. Lucille Roybal-Allard (D-CA) and Karen Bass (D-CA) and hosted in partnership with Drugs for Neglected Diseases initiative (DNDi), Global Health Technologies Coalition (GHTC), The American Society for Tropical Medicine and Hygiene, and Doctors Without Borders/Médecins Sans Frontières (MSF). Kaitlin Christenson of GHTC served as the event’€™s moderator. Other panelists included DNDi’€™s Rachel Cohen; Brian D’€™Cruz, MD, of Doctors Without...
Neglected tropical diseases (NTDs) are a group of 17 bacterial and parasitic infections that affect more than 1.4 billion people worldwide. NTDs are both infectious and chronic and disproportionately affect people in poverty. The U.S. has played an important role in the fight against NTDs, particularly through the NTD program at USAID. Although the program is extremely successful and has delivered treatments to more than 250 million people worldwide, currently the program only focuses on five of the seventeen NTDs. The remaining twelve are often overlooked, in part because existing tools are simply not sufficient to treat these NTDs. To discuss these issues and more, please join us on...

Sidebar Quote

The capabilities are enormous, a little bit of research can pay off quite a bit in the long run.
Paul D’ Addario, retinitis pigmentosa patient